NasdaqCM:EXASBiotechs
Is It Time To Reassess Exact Sciences (EXAS) After The US$105 Abbott Offer?
If you are wondering whether Exact Sciences is still worth your attention at current prices, the key question is how its market value compares with what the business may be worth on paper.
The stock last closed at US$103.24, with returns of 0.1% over 7 days, 1.0% over 30 days, 1.5% year to date, 109.4% over 1 year, 62.6% over 3 years, and a 30.2% decline over 5 years.
Recent news around Exact Sciences has focused on its position in cancer diagnostics and how its core products fit into...